Skip to content

COMPARISON OF TWO LOCAL ANAESTHETIC DRUGS (ROPIVACAINE AND LEVOBUPIVACAINE) FOR NERVE BLOCK IN PATIENTS UNDERGOING UPPER LIMB SURGERY

COMPARISON OF ROPIVACAINE AND LEVOBUPIVACAINE FOR ULTRASOUND GUIDED BRACHIAL PLEXUS BLOCK IN ADULT PATIENTS UNDERGOING UPPER LIMB SURGERY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036773
Enrollment
42
Registered
2021-09-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: ULTRASOUND GUIDED BRACHIAL PLEXUS BLOCK IN ADULT PATIENTS UNDERGOING UPPER LIMB SURGERY: COMPARISON OF ROPIVACAINE AND LEVOBUPIVACAINE FOR ULTRASOUND GUIDED BRACHIAL PLEXUS BLOCK IN ADU

Sponsors

ABVIMS AND DRRML HOSPITAL
Lead Sponsor
ABVIMS AND DRRML HOSPITAL
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years 2. ASA Grade I & II 3. Patients scheduled for upper limb orthopedic surgeries

Exclusion criteria

Exclusion criteria: 1. Patients with infection at the site of injection. 2. Patients with known history of allergy to any of the study medications . 3. Patients with bleeding disorders and those on anti-coagulant therapy. 4. Patients with neurological disorders and neuropathy. 5. Failure of block (in these patients, general anaesthesia will be supplemented).

Design outcomes

Primary

MeasureTime frame
To study the duration of sensory and motor blockade of ropivacaine and levobupivacaine in Ultrasound guided supra-clavicular brachial plexus block for upper limb surgeries.Timepoint: Time of giving supraclavicular brachial plexus block is taken as baseline (0 minutes). Patient is monitored every 15 mins in the intraoperative period followed by every 1 hour in the postoperative period upto 24 hours.

Secondary

MeasureTime frame
To study the hemodynamic profile (HR, SBP, DBP, MAP, SPO2) in both the groupsTimepoint: HR, SBP, DBP, MAP, SPO2 will be monitored every 2 hours for the first 6 hours and thereafter every 4 hours till the need for rescue analgesia.

Countries

India

Contacts

Public ContactKarthiga Manoharan

ABVIMS AND DR.RML HOSPITAL

drvinoddhir@gmail.com9868223931

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026